Community Guidelines

1. Be respectful

• No harassment, threats, bullying, stalking, hate speech, or personal attacks.
• No discrimination or degrading content based on a protected or personal characteristic.
• Disagree with ideas without targeting, intimidating, or exposing another person.

2. Keep the community safe

• No sexual, exploitative, graphically violent, or otherwise objectionable content.
• No content that promotes self-harm, dangerous misuse of medicines, or illegal activity.
• No impersonation, scams, spam, malware, or deceptive links.
• No publication of another person’s private or identifying information.

PharmaTarget has zero tolerance for abusive behavior and objectionable content.

3. Protect patients and professional boundaries

• Do not post patient information, prescriptions, records, images, or other identifiable health data.
• Do not use community discussion as a substitute for clinical judgment or professional advice.
• Do not encourage unsafe treatment, dispensing, or medicine-use decisions.

4. Respect exam and content rights

• Do not share recalled, stolen, confidential, or copyrighted examination questions.
• Do not copy or redistribute PharmaTarget lessons, questions, media, or paid content.
• Use brief quotations only where lawful and give appropriate attribution to public sources.

5. Reporting, blocking, and moderation

When community features are available, use the in-app reporting and blocking controls provided with those features. You may also report a concern to pharmatargetowner@gmail.com. Include enough context to identify the content, but do not forward unnecessary private information.

We may review reports, remove content, limit features, suspend accounts, or preserve and disclose information when reasonably necessary to enforce these guidelines, protect people, or comply with law. Serious or repeated violations may result in permanent loss of access.

6. Questions and appeals

To ask about a moderation decision, email pharmatargetowner@gmail.com from your account email and describe the decision you want reviewed. Use of any community feature also remains subject to the Terms of Use and Privacy Policy.